Laddar...

State of the art in CAR T cell therapy for CD19(+) B cell malignancies

Cellular therapy for hematologic malignancies is a rapidly evolving field, with new iterations of novel constructs being developed at a rapid pace. Since the initial reports of chimeric antigen receptor T cell (CAR T cell)success in CD19(+) B cell malignancies, multiple clinical trials of CAR T cell...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Clin Invest
Huvudupphovsmän: Frigault, Matthew J., Maus, Marcela V.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Clinical Investigation 2020
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7108913/
https://ncbi.nlm.nih.gov/pubmed/32235098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI129208
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!